Literature DB >> 6183452

Avian sarcoma virus gag precursor polypeptide is not processed in mammalian cells.

V M Vogt, D A Bruckenstein, A P Bell.   

Abstract

We studied intracellular avian gag proteins (internal structural proteins of virions) in several mammalian cell lines transformed by Rous sarcoma virus. All lines examined contain gag antigens as determined by radioimmune assay. We used the techniques of protein blotting from polyacrylamide gels, which detects nanogram quantities of viral protein, to investigate the size of intracellular viral polypeptides. All of the lines that contained enough viral protein to be amenable to this type of analysis synthesized Pr76, the avian sarcoma virus gag precursor polypeptide, but failed to process it into mature virion proteins. In some cell lines, the recovery of Pr76 was greatly enhanced by the addition of a mixture of protease inhibitors, including the sulfhydryl-blocking reagent N-ethylmaleimide, to the lysis buffer. At least several of the mammalian cells also synthesized a viral polypeptide the size of Pr180, the precursor to reverse transcriptase. Since Rous sarcoma virus does not replicate or replicates extremely poorly in mammalian cells, the lack of processing suggests that cleavage and virion assembly are invariably associated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183452      PMCID: PMC256320     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Synthesis of avian RNA tumor virus structural proteins.

Authors:  R Eisenman; V M Vogt; H Diggelmann
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

2.  Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide.

Authors:  V M Vogt; R Eisenman; H Diggelmann
Journal:  J Mol Biol       Date:  1975-08-15       Impact factor: 5.469

3.  Cleavage of Rous sarcoma viral polypeptide precursor into internal structural proteins in vitro involves viral protein p15.

Authors:  K von der Helm
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

4.  Comparative study of RSV rescue from RSV-transformed mammalian cells.

Authors:  J Svoboda; O Machala; L Donner
Journal:  Int J Cancer       Date:  1971-11-15       Impact factor: 7.396

5.  Investigations on virus production in RSV mammalian tumours.

Authors:  H Gelderblom; H Bauer; H Frank
Journal:  J Gen Virol       Date:  1970-04       Impact factor: 3.891

Review 6.  The biosynthesis of oncovirus proteins.

Authors:  R N Eisenman; V M Vogt
Journal:  Biochim Biophys Acta       Date:  1978-04-06

7.  Frog oocytes synthesize and completely process the precursor polypeptide to virion structural proteins after microinjection of avian myeloblastosis virus RNA.

Authors:  J Ghysdael; E Hubert; M Trávnícek; D P Bolognesi; A Burny; Y Cleuter; G Huez; R Kettmann; G Marbaix; D Portetelle; H Chantrenne
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

8.  Type C viral gag gene expression in chicken embryo fibroblasts and avian sarcoma virus-transformed mammalian cells.

Authors:  F H Reynolds; C A Hanson; S A Aaronson; J R Stephenson
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

9.  Murine leukemia virus morphogenesis: cleavage of P70 in vitro can be accompanied by a shift from a concentrically coiled internal strand ("immature") to a collapsed ("mature") form of the virus core.

Authors:  Y Yoshinaka; R B Luftig
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

10.  Ribonuclease-sensitive deoxyribonucleic acid polymerase activity in uninfected rat cells and rat cells infected with Rous sarcoma virus.

Authors:  J M Coffin; H M Temin
Journal:  J Virol       Date:  1971-11       Impact factor: 5.103

View more
  18 in total

1.  Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly.

Authors:  R C Craven; R P Bennett; J W Wills
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

2.  Incorporation of chimeric gag protein into retroviral particles.

Authors:  R A Weldon; C R Erdie; M G Oliver; J W Wills
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

3.  Myristylation of Rous sarcoma virus Gag protein does not prevent replication in avian cells.

Authors:  C R Erdie; J W Wills
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Comparison of Rous sarcoma virus RNA processing in chicken and mouse fibroblasts: evidence for double-spliced RNA in nonpermissive mouse cells.

Authors:  S L Berberich; M Macias; L Zhang; L P Turek; C M Stoltzfus
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids.

Authors:  S S Rhee; E Hunter
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

6.  Rous sarcoma virus direct repeat cis elements exert effects at several points in the virus life cycle.

Authors:  S B Simpson; L Zhang; R C Craven; C M Stoltzfus
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells.

Authors:  J W Wills; R C Craven; J A Achacoso
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

8.  Hematopoietic cell transformation by a murine recombinant retrovirus containing the src gene of Rous sarcoma virus.

Authors:  J H Pierce; S A Aaronson; S M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus.

Authors:  E V Barsov; S H Hughes
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Production of avian leukosis virus particles in mammalian cells can be mediated by the interaction of the human immunodeficiency virus protein Rev and the Rev-responsive element.

Authors:  G Nasioulas; S H Hughes; B K Felber; J M Whitcomb
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.